Eli Lilly

Page 6 of 7

Eli Lilly COVID drug cocktail
Health

COVID treatments like the experimental antibody therapeutic Trump received are making progress

By
October 7, 2020
General Views of Eli Lilly & Co.
Newsletters

Eli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results

By
September 17, 2020
Eli Lilly Earnings Diabetes Sales
Newsletters

Eli Lilly smashed Wall Street projections thanks to its diabetes drugs

By
January 30, 2020
Coins2Day
Health

3 Drug Giants Win a Legal Victory Against Trump—For Now: Brainstorm Health

By
July 9, 2019
Drug price TV ad lawsuit
Health

Big Drug Makers Sue to Block Mandatory Price Disclosures in TV Ads: Brainstorm Health

By
June 14, 2019
Migraine, Illustration
Health

The FDA Just Approved a Third Migraine Drug—and It’s Free (At Least for Now)

By
September 28, 2018
Alzheimers-dementia-brain-research
Health

Eli Lilly, AstraZeneca’s Alzheimer’s Drug Flop Is the Latest Disappointment in a Frustrating Disease

By
June 12, 2018
U.S. Multinationals in Puerto Rico
Health

Eli Lilly CEO Welcomes Amazon’s Arrival in the Health Care Business

By
January 31, 2018
COLOMBIA-YARUMAL-ALZHEIMER
Health

Alzheimer’s Cases Are Expected to Double By 2060 and We’re Not Ready for It

By
December 7, 2017
BioGen Alzheimers
Health

We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?

By
November 2, 2017
BioGen Alzheimers
Health

Could a New Immunotherapy Medical Approach Break the Alzheimer’s Drug Curse?

By
October 24, 2017
Man walks downstairs
Health

Big Pharma Just Had a Terrible, Horrible, No Good, Very Bad Week of Job Cuts

By
December 12, 2016
Mobile World Congress - Day 1

Microsoft Gets Backup in Its Fight Against U.S. Government Gag Orders

By
September 6, 2016
Eli Lilly & Co Chief Executive Officer John Lechleiter Interview
Health

Eli Lilly to Continue Breakthrough Breast Cancer Drug Trial Despite Failed Test

By
August 11, 2016
Eli Lilly & Co Chief Executive Officer John Lechleiter Interview
Health

Eli Lilly’s CEO John Lechleiter Is Retiring at the End of the Year

By
July 27, 2016

Most Popular